Clinical Trial Update: The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing tacrolimus versus sirolimus immunosuppression regimens in kidney transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Prograf (Tacrolimus)
• Rapamune (sirolimus)

Snippet

Sponsor: Mayo Clinic | Conditions: Kidney Diseases | Phase 4 | Status: COMPLETED